Understanding the Stakes: Lung Cancer and the PD-L1 Challenge Lung cancer is the most diagnosed cancer worldwide, with nearly two million new cases reported each year. Among its types, non-small cell lung cancer (NSCLC) dominates […]
SOX9 as a Prognostic Marker in Gastric Adenocarcinoma Introduction Gastric cancer (GC) is one of the most common and deadly types of cancer worldwide. Each year, more than one million people are diagnosed with GC. […]
Lung cancer is the leading cause of cancer-related deaths globally, with nearly 2.5 million new cases annually. Non-small cell lung cancer (NSCLC) accounts for approximately 80%–85% of all lung cancer cases. Most patients are diagnosed […]
For the past four decades, the 67 kDa laminin receptor (67LR) has been a central focus of cancer research, especially in the study of colorectal carcinoma. This receptor was hypothesized to consist of a complex […]
Kaposi sarcoma (KS) is a rare disease, and there is no specific treatment protocol agreed upon, especially for the classical type. Chemotherapeutics such as paclitaxel, pegylated liposomal doxorubicin (PLD), etoposide, gemcitabine are used in the […]
Cancer is a condition in which the cells in a specific part of the body grow and reproduce uncontrollably. The cancerous cells can invade and destroy surrounding healthy tissue, including organs. Furthermore, cancer is among […]
Background Renal cell carcinoma (RCC) represents the 15th most common cancer worldwide. About 20% of patients with renal cell carcinoma eventually develop liver metastasis (LM). Furthermore, the liver is the only site of distant spread […]
Despite the numerous developments in the diagnosis and treatment of gastric cancer, it continues to be an important public health problem. Therefore, besides classical methods, the new biomolecules are needed to facilitate the prediction of […]
Copyright (c) 2021 Association of Basic Medical Sciences of FBIH